Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

INAB

INAB News

Newswire

08:19

In8bio shares rise 10.11% premarket after director Jeremy Graff buys 2,500 shares.

16:34

IN8bio shares surge 11.72% after-hours on promising DeltEx therapy clinical trial results for glioblastoma.

13:33

IN8bio shares surge 12.94% intraday after presenting promising DeltEx glioblastoma trial results showing improved survival rates.

16:06

IN8bio Q3 2025: INB-619 data, Phase 1 trial expansion, and GBM update.

08:09

Ohio State joins IN8bio's Phase 1 trial for INB-100 cancer therapy.

View More

About INAB

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More